Ambulatory Medicament Device Gesture Control Software Updates
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current glucose control systems for ambulatory medical devices face challenges in maintaining uninterrupted therapy delivery during software updates and managing user interactions, alarm management, and data connectivity, which can disrupt the continuous monitoring and treatment of blood glucose levels.
Innovation Solution
The implementation of software update techniques that allow for seamless application updates without interrupting therapy, gesture-based control for user interaction, improved alarm management, and wide area network connectivity to ensure continuous glucose monitoring and therapy delivery.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If software updates are performed on the ambulatory medical device, then the device functionality and performance are improved, but the therapy delivery may be interrupted
Solution Approach 1:
The patent divides the software update process into separate phases: downloading the update during non-therapy periods, validating the update in a sandbox environment, and applying it during scheduled maintenance windows. This segmentation allows software improvements without interrupting critical therapy delivery to the patient.
Solution Approach 2:
The patent implements preliminary validation and testing of software updates before they are applied to the production system. Updates are first installed in a sandbox environment, tested for safety and functionality, and only after successful validation are they deployed to the ambulatory medical device, ensuring reliability is maintained.
2Ease of operation
If traditional button-based control interfaces are used, then device operation is reliable, but user interaction efficiency and ease of use are limited
Solution Approach 1:
The patent replaces mechanical button-based controls with gesture-based control interfaces that detect and interpret user movements. This substitution allows for more intuitive and efficient user interaction while maintaining reliability through multiple validation layers for gesture recognition and authorization.
3Reliability
If local area network connectivity is used, then data transmission is reliable, but connectivity coverage and accessibility are limited
Solution Approach 1:
The patent implements multiple communication interfaces including both local area network and wide area network capabilities. The system can automatically select the appropriate connectivity method based on availability, ensuring data transmission reliability while expanding coverage to remote locations through cellular or other wide area network options.
4Ease of operation
If gesture-based control is implemented, then user interaction becomes more intuitive, but false activation from device motion may occur
Solution Approach 1:
The patent incorporates feedback mechanisms where the system analyzes the context and pattern of detected gestures, cross-references them with user profiles and current device states, and provides confirmation prompts for critical actions. This feedback loop ensures that only intentional, validated gestures trigger device functions, preventing false activation while maintaining intuitive control.
Data Source
AI summary
Ambulatory medicament devices that provide therapy to a subject, such as blood glucose control, are disclosed. Disclosed systems and methods can implement one or more features that improve the user experience, by modifying delivery of therapy to a subject after determining that a possible occlusion exists in a medicament delivery system, monitoring the status of an ambulatory medical device and the health condition of a subject that receives therapy from the ambulatory medical device and annunciating alarm condition when necessary, selectively muting alarm annunciations while a Do Not Disturb mode is activated, implementing various power saving modes to save power, controlling operation of the device and medicament delivery based on the user gesture controls, and controlling medicament delivery based on a condition of the ambulatory medicament device.